Clinical Trials for Salivary Gland Cancer

Find clinical trials for salivary gland cancer. Discover research opportunities and treatment options in your area.

11 Active Trials Found

Showing 11 trials on this page

Page 1 of 1

Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)

NCT ID: NCT02628067

This clinical trial is studying a medication called pembrolizumab (MK-3475) for people with advanced solid tumors that have not responded to standard treatments. The trial aims to see how well this...

Recruiting

Phase: PHASE2 Type: interventional Locations: North Ryde, , Australia, Midrand, , South Africa +29 more

Integrated Cancer Repository for Cancer Research

NCT ID: NCT02012699

The Integrated Cancer Repository for Cancer Research (iCaRe2) is a study designed to gather important information and samples from adults who have been diagnosed with cancer, those at high risk for...

Recruiting

Type: observational Locations: Pittsburgh, Pennsylvania, United States, Denver, Colorado, United States +93 more

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

NCT ID: NCT06695845

This clinical trial is studying a new treatment called zanidatamab for patients with certain types of solid tumors that have high levels of a protein called HER2. These tumors include breast, gastr...

Recruiting

Phase: PHASE2 Type: interventional Locations: Detroit, Michigan, United States, Houston, Texas, United States +19 more

A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers

NCT ID: NCT06805617

This clinical trial is studying a new treatment called Ivonescimab for patients with advanced salivary gland cancers, which are types of cancer that can spread to other parts of the body. The main ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Boston, Massachusetts, United States, Boston, Massachusetts, United States

Sacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers (SG-SGTC)

NCT ID: NCT06923826

This clinical trial is studying a drug called sacituzumab govitecan to see if it can effectively treat certain types of advanced salivary gland and thyroid cancers. Specifically, the trial focuses ...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Singapore, , Singapore

Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas

NCT ID: NCT04620187

This clinical trial is studying the combination of a new drug called Ado-trastuzumab emtansine (T-DM1) with standard treatments for HER2-positive salivary gland cancer. The main goal is to see if t...

Recruiting

Phase: PHASE2 Type: interventional Locations: Boston, Massachusetts, United States, Chicago, Illinois, United States +10 more

Enhanced Assistance During Radiotherapy for Unmet Essential Needs

NCT ID: NCT06582849

This clinical trial is exploring how providing extra support can help patients with certain cancers complete their radiotherapy treatments without delays. Radiotherapy is a common treatment that us...

Recruiting

Phase: NA Type: interventional Locations: Saint Louis, Missouri, United States

The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers

NCT ID: NCT05483374

The Head and Neck Registry is a clinical trial focused on understanding rare types of head and neck cancers, such as nasopharynx cancer, nasal cavity cancer, and salivary gland cancer. The goal of ...

Recruiting

Type: observational Locations: Milano, , Italy, Brno, , Czechia +12 more

Gene Expression Profiling in a Validation Cohort of Locally Advanced and Recurrent/Metastatic Salivary Gland Cancers

NCT ID: NCT06091878

The INDAGA-UK trial is a study focused on understanding salivary gland cancer, particularly in patients whose cancer is advanced or has come back after treatment. Researchers will look at tissue sa...

Not yet recruiting

Type: observational

Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients

NCT ID: NCT03924466

This clinical trial is investigating a new imaging technique using a special substance called 68GaNOTA-Anti-HER2 VHH1 to help doctors see and measure tumors in patients with certain types of cancer...

Recruiting

Phase: PHASE2 Type: interventional Locations: Brussels, Brussel, Belgium

Vedicitumomab Alone or in Combination for the Treatment of Locally Advanced or Metastatic SDC

NCT ID: NCT05898373

The clinical trial titled "Vedicitumomab Alone or in Combination for the Treatment of Locally Advanced or Metastatic SDC" is investigating a new treatment for salivary gland cancer, specifically th...

Not yet recruiting

Phase: PHASE1 Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions